“As a leading innovator in cardiovascular care, we are committed to support care providers and their patients with integrated solutions to address their biggest challenges,” said Bert van Meurs, Business Leader, Image Guided Therapy. “By seamlessly connecting data, technology and people across the health continuum, we’re bridging the gap in patient flow before entrance to the hospital and after discharge, helping to reduce costs and achieve optimal outcomes for patients.”
At ACC.18 Philips will also announce the presentation of new one-year follow-up DEFINE FLAIR trial data on the comparative cost effectiveness of using an iFR-guided strategy in the assessment of coronary blockages when compared to an FFR-guided strategy. This is intended to build on the DEFINE FLAIR trial data announced during ACC.17, which found that iFR-guided treatments offer a 10 percent reduction in procedural time versus FFR-guided treatments, while reducing patient discomfort by 90 percent. iFR technology is proprietary to Philips.
Philips’ image-guided therapy solutions comprise interventional imaging systems, smart devices, software and services that enable clinicians to decide, guide, treat and confirm the appropriate cardiac and peripheral vascular treatment. On-site at ACC.18 Philips is exhibiting a range of integrated solutions for interventional cardiovascular procedures, including:
- Azurion, Philips’ next generation image-guided therapy platform, which enables clinicians to easily and confidently perform a range of routine and complex procedures, helping them to optimize interventional lab performance and provide superior care.
- New instant wave-Free Ratio (iFR) technology, iFR Roadmap, exclusive to Philips' interventional labs, which enables physicians to navigate coronary arteries and corresponding iFR data in real time.
- Philips’ SyncVision iFR co-registration solution, which couples iFR physiology measurement pull-back results to the coronary angio, which can be utilized in the stenting process when lesions are more complex.
- EchoNavigator, which automatically fuses live 3D TEE and live X-ray in real time so you can intuitively guide your device in the 3D space more quickly.
At ACC.18 Philips is also showcasing the latest innovations from its TOMTEC portfolio of intelligent image analysis software for automation and quantification in cardiac ultrasound, alongside a range of advanced ultrasound solutions, including:
- EPIQ with HeartModel, featuring the X8-2t Live 3D transesophageal transducer, the next level of cardiac imaging for fast, easy, and accurate transesophageal echocardiography that enables clinicians to diagnose surgical pathology in real time.
- Affiniti, supporting X7-2t Live 3D TEE, to deliver greater confidence and expand access to 3D transesophageal imaging to a wider range of patients.
- Lumify, now with the addition of the S4-2 phased-array transducer and cardiac exam preset, to deliver exceptional cardiac imaging and triage on any compatible Android device.
At Philips, we create scalable and interoperable health information management solutions that seamlessly connect data, technology and people across the care continuum. At ACC.18 Philips is showcasing the latest Healthcare Informatics innovations, including:
- IntelliSpace Cardiovascular 3.1, Philips’ next-generation cardiovascular image and information management system. Designed to help streamline workflow and improve operational performance throughout the cardiovascular service line, the latest version features enhanced security and enterprise protocols, seamless access to Philips’ QLAB and TOMTEC software tools, and the addition of browser-based reporting of stress echocardiogram (stress echo) tests.
- IntelliSpace Portal 10, the latest edition of Philips’ comprehensive, advanced visualization and quantification platform, was recently named 2018 Category Leader in the Advanced Visualization category in the 2018 Best in KLAS: Software & Services report.
For more information on Philips' integrated cardiology solutions, visit Philip’s booth (#2811) at ACC.18 or visit the Philips event page. Follow the #ACC18 conversation on @PhilipsLiveFrom throughout the event.
Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017
iFR Roadmap is not a standalone technology. It can only be purchased as part of the Dynamic Coronary Roadmap package.
The complete report is available for download at http://www.klasresearch.com/.